Unique structural features of firmonertinib enhance binding and activity against EGFR mutant proteins including ex20ins mutant proteins in cell lines and NSCLC animal modelsSuperior anti-tumor ...
Aarvik Therapeutics , an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer ther ...
For more than a century, the billboard business depended on printing. Today, that relationship is beginning to unravel.
PHILADELPHIA and VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, ...
Peloton Interactive (NASDAQ:PTON) shares are surging more than 10% in morning trading today after the company announced it is officially heading to the gym. The connected-fitness pioneer unveiled its ...
US retail giant Target has reported another quarter of declining sales and profits, as the retailer struggles to regain its footing with customers grappling with widespread price increases. However, ...
Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced it will present a poster on one of the ...
Two abstracts accepted for presentationOne abstract on new additional biomarker and immunogenicity data for personalized cancer vaccine EVX-01Another abstract on the use of Evaxion's AI-Immunology pla ...
Target reported another quarter of declining sales and profits as the retailer struggles to regain its footing with its ...
An Iranian media outlet affiliated with the Iranian Revolutionary Guard Corps, Tasnim news agency, released a list of offices ...
New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR?)-targeting ant ...
Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results